BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33348918)

  • 1. Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.
    Soltysova A; Sedlackova T; Dvorska D; Jasek K; Chokhachi Baradaran P; Horvathova Kajabova V; Demkova L; Buocikova V; Kurucova T; Lyskova D; Furdova A; Minarik G; Babal P; Dankova Z; Smolkova B
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and molecular landscape of melanoma: implications for targeted therapy.
    Beigi YZ; Lanjanian H; Fayazi R; Salimi M; Hoseyni BHM; Noroozizadeh MH; Masoudi-Nejad A
    Mol Biomed; 2024 May; 5(1):17. PubMed ID: 38724687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrence of chromosome 3 and 4 aberrations in human uveal melanoma.
    Sipos E; Hegyi K; Treszl A; Steiber Z; Mehes G; Dobos N; Fodor K; Olah G; Szekvolgyi L; Schally AV; Halmos G
    Oncol Rep; 2017 Apr; 37(4):1927-1934. PubMed ID: 28350068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease.
    Neo SY; Oliveira MMS; Tong L; Chen Y; Chen Z; Cismas S; Burduli N; Malmerfelt A; Teo JKH; Lam KP; Alici E; Girnita L; Wagner AK; Westerberg LS; Lundqvist A
    J Exp Clin Cancer Res; 2024 Jan; 43(1):13. PubMed ID: 38191418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decoding the molecular landscape: A novel prognostic signature for uveal melanoma unveiled through programmed cell death-associated genes.
    Liu Z; Yu L; Lai J; Zhang R
    Medicine (Baltimore); 2024 May; 103(18):e38021. PubMed ID: 38701273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin Impairs the Growth of Uveal Melanoma Cells by Interfering with Glucose Uptake and Metabolism.
    Tura A; Herfs V; Maaßen T; Zuo H; Vardanyan S; Prasuhn M; Ranjbar M; Kakkassery V; Grisanti S
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
    Gelmi MC; Gezgin G; van der Velden PA; Luyten GPM; Luk SJ; Heemskerk MHM; Jager MJ
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):36. PubMed ID: 38149971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.
    Sato T; Montazeri K; Gragoudas ES; Lane AM; Aronow MB; Cohen JV; Boland GM; Banks E; Kachulis C; Fleharty M; Cibulskis C; Lawless A; Adalsteinsson VA; Sullivan RJ; Kim IK
    JCO Precis Oncol; 2024 Jan; 8():e2300368. PubMed ID: 38237100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent approaches for the treatment of uveal melanoma: Opportunities and challenges.
    Khan SA; Almalki WH; Arora S; Kesharwani P
    Crit Rev Oncol Hematol; 2024 Jan; 193():104218. PubMed ID: 38040071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases.
    Jager MJ; Dogrusöz M; Woodman SE
    Asia Pac J Ophthalmol (Phila); 2017; 6(2):179-185. PubMed ID: 28399339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells.
    Aya-Bonilla CA; Morici M; Hong X; McEvoy AC; Sullivan RJ; Freeman J; Calapre L; Khattak MA; Meniawy T; Millward M; Ziman M; Gray ES
    Br J Cancer; 2020 Mar; 122(7):1059-1067. PubMed ID: 32037400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.
    Beasley AB; Isaacs TW; Vermeulen T; Freeman J; DeSousa JL; Bhikoo R; Hennessy D; Reid A; Chen FK; Bentel J; McKay D; Conway RM; Pereira MR; Mirzai B; Calapre L; Erber WN; Ziman MR; Gray ES
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and Molecular Diagnosis of Uveal Melanoma.
    Păsărică MA; Curcă PF; Dragosloveanu CDM; Grigorescu AC; Nisipașu CI
    Diagnostics (Basel); 2024 May; 14(9):. PubMed ID: 38732371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome Measures of New Technologies in Uveal Melanoma: Review from the European Vision Institute Special Interest Focus Group Meeting.
    Beenakker JM; Brouwer NJ; Chau C; Coupland SE; Fiorentzis M; Heimann H; Heufelder J; Joussen AM; Kiilgaard JF; Kivelä TT; Piperno-Neumann S; Rantala ES; Romanowska-Dixon B; Shields CL; Willerding GD; Wheeler-Schilling T; Scholl HPN; Jager MJ; Damato BE;
    Ophthalmic Res; 2023; 66(1):14-26. PubMed ID: 35358966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-Platform Identification and Validation of Uveal Melanoma Vitreous Protein Biomarkers.
    Velez G; Wolf J; Dufour A; Mruthyunjaya P; Mahajan VB
    Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):14. PubMed ID: 37955612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study.
    Guadagni S; Fiorentini G; Papasotiriou I; Apostolou P; Masedu F; Sarti D; Farina AR; Mackay AR; Clementi M
    BMC Res Notes; 2020 Mar; 13(1):176. PubMed ID: 32204733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas.
    Mobuchon L; Derrien AC; Houy A; Verrier T; Pierron G; Cassoux N; Milder M; Deleuze JF; Boland A; Scelo G; Cancel-Tassin G; Cussenot O; Rodrigues M; Noirel J; Machiela MJ; Stern MH
    J Natl Cancer Inst; 2022 Feb; 114(2):302-309. PubMed ID: 34424336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates in the Management of Uveal Melanoma.
    Barbi M; Carvajal RD; Devoe CE
    Cancer J; 2024 Mar-Apr 01; 30(2):92-101. PubMed ID: 38527262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying biomarkers and novel therapeutic targets in uveal melanoma.
    Wessely A; Koch EAT; Vera J; Berking C; Heppt MV
    J Dtsch Dermatol Ges; 2024 Jan; 22(1):29-32. PubMed ID: 37902386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of neoplastic-immune hybrid cells with metastatic properties in uveal melanoma.
    Anderson AN; Conley P; Klocke CD; Sengupta SK; Pang A; Farley HC; Gillingham AR; Dawson AD; Fan Y; Jones JA; Gibbs SL; Skalet AH; Wu G; Wong MH
    Res Sq; 2023 Dec; ():. PubMed ID: 38106024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.